Country for PR: United Kingdom
Contributor: PR Newswire Europe
Tuesday, August 27 2019 - 19:32
AsiaNet
Health Canada Clears Fotona Dynamis for Stress Urinary Incontinence (SUI) and Vulvovaginal Atrophy (VVA) / Genitourinary Syndrome of Menopause (GSM)
LJUBLJANA, Slovenia, Aug. 27, 2019 /PRNewswire-AsiaNet/ --

- Fotona's Cutting Edge Dynamis Laser System Earns Industry First Clearance

In an industry first achievement, Fotona's Dynamis Laser System received 
clearance by Health Canada, Canada's Food and Drugs Act and Regulations Agency, 
to treat stress urinary incontinence (SUI) and vulvovaginal atrophy (VVA) / 
genitourinary syndrome of menopause (GSM). Treatment for these conditions can 
be achieved by using the proprietary Fotona SMOOTH(R) Er:YAG modality and 
robotic G-Runner and G-set handpieces and speculums, which were specially 
designed for ease of use and precision during intravaginal treatments. After 
extensive review of detailed documentation and published studies performed with 
Fotona's Dynamis laser system, clearance was granted by Health Canada, further 
validating Fotona's commitment to evidence-based medicine. 
 
The patented Fotona SMOOTH(R) technology holds a very unique position in the 
market, making it a leading solution for providers and patients. Unlike 
competing laser technologies, Fotona SMOOTH(R) is completely non-ablative and 
combines an additional superficial heat-shocking mechanism of tissue 
regeneration with a unique self-regulating safety feature. These dual-tissue 
regeneration characteristics of Fotona SMOOTH(R) are believed to be responsible 
for the reported extraordinary safety and efficacy of Fotona's Er:YAG lasers 
when used for thermotherapy of the vaginal wall to alleviate symptoms of stress 
urinary incontinence and genitourinary syndrome of menopause.

Combining two complementary wavelengths, 1064nm and 2940nm, with Fotona's 
proprietary pulse characteristics, the Dynamis PRO is a multi-purpose system 
that is capable of performing a wide range of applications, not only in 
gynecology but also in surgery and aesthetics. The robotic G-Runner enables 
revolutionary intravaginal treatments with ease and precision. This innovative 
technology is why providers choose Fotona to achieve optimal outcomes for their 
patients and further establish their practices as best-in-class.

This clearance is yet another achievement for Fotona, marking the first of its 
kind in the laser industry. Known globally for its continuous dedication to 
developing industry-leading technology, Fotona has earned its place as the gold 
standard in laser technology for health providers and patients around the world.

ABOUT FOTONA

Fotona (www.fotona.com) has sold over 30,000 lasers around the world, with 
direct sales in the U.S. and distribution in over 60 countries. Fotona produces 
award-winning lasers in dentistry, aesthetics, dermatology, gynecology & other 
medical fields. Fotona has one of the most highly educated workforces in the 
industry, with an exceptionally high number of PhDs specializing in laser and 
medical technology. Strong R&D capabilities have always been a key competitive 
advantage of the company, resulting in many patented solutions, including the 
Optoflex(R) articulated arm, Quantum Square Pulse and Variable Square Pulse 
technologies, Fotona SMOOTH(R) mode, Vacuum Cell technology, and more. 

The company manufactures all of its laser systems in-house, ensuring that each 
system is of the highest quality, reliability, ease-of-use and durability, in 
compliance with all applicable international standards. When you choose Fotona, 
you choose a company that aims to continuously Choose Perfection to meet the 
needs of a highly demanding marketplace.

Logo - https://mma.prnewswire.com/media/966027/Fotona_Logo.jpg
 
CONTACT:
Ladislav Grad 
info@fotona.com  
(+386)-1-5009-100

Source: Fotona
Translations

Japanese